全球臨床試驗影像市場規模、佔有率、趨勢及成長分析報告（2026-2034）

臨床試驗診斷影像市場預計將從 2025 年的 18 億美元成長到 2034 年的 37.9 億美元，2026 年至 2034 年的複合年成長率預計為 8.61%。

受腫瘤學、心臟病學和神經病學領域臨床試驗數量不斷增加的推動，全球臨床試驗影像市場正在快速擴張。影像在評估治療效果和監測疾病進展方面發揮著至關重要的作用。製藥和生物技術公司擴大將影像服務外包給專業供應商。

成長要素包括研發投入增加、對生物標記主導試驗的需求不斷成長，以及磁振造影（MRI）和電腦斷層掃描）等影像技術的進步。監管機構對精確資料收集的重視正在推動標準化成像通訊協定的普及。此外，個人化醫療的興起也進一步推動了先進影像解決方案的需求。

未來前景光明，人工智慧和雲端診斷成像平台的融合將提升數據分析和協作能力。新興市場臨床研究活動的拓展將進一步推動成長。持續的技術進步和不斷成長的藥物開發平臺有望支撐市場的長期擴張。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章 全球臨床試驗影像市場：依產品與服務分類

• 市場分析、洞察與預測
• 服務
• 軟體

第5章 全球臨床試驗影像市場：依影像方式分類

• 市場分析、洞察與預測
• 電腦斷層掃描
• 磁振造影
• 心臟超音波圖
• 核子醫學
• 正子斷層掃描
• X光
• 超音波
• 光同調斷層掃瞄
• 其他

第6章 全球臨床試驗影像市場：依應用領域分類

• 市場分析、洞察與預測
• 腫瘤學
• 神經病學
• 內分泌學
• 心臟病學
• 皮膚科
• 血液學
• 其他

第7章 全球臨床試驗影像市場：依最終使用者分類

• 市場分析、洞察與預測
• 製藥和生物技術公司
• 受託研究機構
• 醫療設備製造商
• 學術研究機構與政府研究機構
• 其他

第8章 全球臨床試驗影像市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第9章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第10章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Navitas Life Sciences
  • Resonance Health Ltd
  • BioTelemetry（A Philips Company）
  • IXICO Plc
  • ICON Plc
  • Image Core Lab
  • Anagram 4 Clinical Trials
  • Quotient Sciences
  • Radiant Sage LLC
  • Worldcare Clinical
  • Clario
  • Parexel International Corporation
  • Median Technologies
  • Perspectum
  • Invicro LLC

The Clinical Trial Imaging Market size is expected to reach USD 3.79 Billion in 2034 from USD 1.80 Billion (2025) growing at a CAGR of 8.61% during 2026-2034.

The Global Clinical Trial Imaging Market is expanding rapidly due to increasing number of clinical trials in oncology, cardiology, and neurology. Imaging plays a vital role in evaluating treatment efficacy and monitoring disease progression. Pharmaceutical and biotechnology companies are increasingly outsourcing imaging services to specialized providers.

Growth drivers include rising R&D investments, growing demand for biomarker-driven trials, and advancements in imaging modalities such as MRI and CT scans. Regulatory emphasis on accurate data collection has strengthened the adoption of standardized imaging protocols. Additionally, the rise of personalized medicine has further fueled demand for advanced imaging solutions.

Future prospects are promising with integration of AI and cloud-based imaging platforms enhancing data analysis and collaboration. Expansion of clinical research activities in emerging markets will further support growth. Continuous technological advancements and increasing drug development pipelines are expected to sustain long-term market expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Services

• Services
• Software

By Modality

• Computed Tomography
• Magnetic Resonance Imaging
• Echocardiography
• Nuclear Medicine
• Positron Emission Tomography
• X-ray
• Ultrasound
• Optical Coherence Tomography
• Others

By Application

• Oncology
• Neurology
• Endocrinology
• Cardiology
• Dermatology
• Hematology
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations
• Medical Device Manufacturers
• Academic and Government Research Institutes
• Others

COMPANIES PROFILED

• Navitas Life Sciences, Resonance Health Ltd, BioTelemetry a Philips Company, IXICO plc, ICON plc, Image Core Lab, anagram 4 clinical trials, Quotient Sciences, Radiant Sage LLC, Worldcare Clinical, Clario, Parexel International Corporation, Median Technologies, Perspectum, Invicro LLC
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY PRODUCT AND SERVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Services
• 4.2. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY MODALITY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Modality
• 5.2. Computed Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Magnetic Resonance Imaging Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Echocardiography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Nuclear Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Positron Emission Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.7. X-ray Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.8. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.9. Optical Coherence Tomography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.10. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY APPLICATION 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Application
• 6.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Endocrinology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.6. Dermatology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.7. Hematology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Medical Device Manufacturers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Academic and Government Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL CLINICAL TRIAL IMAGING MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Product And Services
  • 8.2.2 By Modality
  • 8.2.3 By Application
  • 8.2.4 By End User
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Product And Services
  • 8.3.2 By Modality
  • 8.3.3 By Application
  • 8.3.4 By End User
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Product And Services
  • 8.4.2 By Modality
  • 8.4.3 By Application
  • 8.4.4 By End User
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Product And Services
  • 8.5.2 By Modality
  • 8.5.3 By Application
  • 8.5.4 By End User
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Product And Services
  • 8.6.2 By Modality
  • 8.6.3 By Application
  • 8.6.4 By End User
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL CLINICAL TRIAL IMAGING INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Navitas Life Sciences
  • 10.2.2 Resonance Health Ltd
  • 10.2.3 BioTelemetry (A Philips Company)
  • 10.2.4 IXICO Plc
  • 10.2.5 ICON Plc
  • 10.2.6 Image Core Lab
  • 10.2.7 Anagram 4 Clinical Trials
  • 10.2.8 Quotient Sciences
  • 10.2.9 Radiant Sage LLC
  • 10.2.10 Worldcare Clinical
  • 10.2.11 Clario
  • 10.2.12 Parexel International Corporation
  • 10.2.13 Median Technologies
  • 10.2.14 Perspectum
  • 10.2.15 Invicro LLC